Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-02-26 @ 11:43 PM
Study NCT ID:
NCT02454634
Status:
COMPLETED
Last Update Posted:
2018-11-07
First Post:
2015-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
Sponsor:
National Center for Tumor Diseases, Heidelberg
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NCT-2013-0216
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None